NCT00937664View on ClinicalTrials.gov

Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
CancerSolid TumorsAdvanced Solid Malignancies
Interventions
DRUG

AZD7762

solution, intravenous, weekly

DRUG

gemcitabine

intravenous, weekly

Trial Locations (1)

Unknown

Research Site, Minamiku

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY